Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03522961 · ClinicalTrials.gov registry record · NA

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

A NA study of Urinary Incontinence and Pelvic Organ Prolapse, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
142
Enrollment target
1
Study location

NCT03522961 is a NA study of Urinary Incontinence and Pelvic Organ Prolapse that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 142 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03522961, a NA study of Urinary Incontinence and Pelvic Organ Prolapse, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
142 participants
Enrollment target
1
Study location

Study Summary

We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence scheduled to have surgery with the Urogynecologists who comprise the Brigham and Women's Urogynecology Group.

Conditions Studied

Urinary Incontinence Pelvic Organ Prolapse Urinary Tract Infections

Interventions

  • DRUG Nitrofurantoin Prophylaxis/Placebo
  • DRUG Cranberry capsules

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2018-08-15
Est. Completion 2026-12-31
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03522961

The ClinicalTrials.gov registry entry for NCT03522961 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (45% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Nitrofurantoin Prophylaxis/Placebo is the first listed.

NCT03522961 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03522961 about?

NCT03522961 is a clinical study titled "Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery". We aim to compare the effectiveness of cranberry capsules versus nitrofurantoin prophylaxis in preventing urinary tract infections (UTIs) after urogynecologic surgery by conducting a double-blinded randomized clinical trial involving women with pelvic organ prolapse and/or urinary incontinence sched...

What is the current status of trial NCT03522961?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2018-08-15. Estimated completion is 2026-12-31.

What conditions does trial NCT03522961 study?

This clinical trial studies the following conditions: Urinary Incontinence, Pelvic Organ Prolapse, Urinary Tract Infections.

What interventions are being tested in trial NCT03522961?

The interventions under investigation include: Nitrofurantoin Prophylaxis/Placebo (DRUG), Cranberry capsules (DRUG).

Who is sponsoring clinical trial NCT03522961?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03522961 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urinary Incontinence

All registered trials for this condition

Pelvic Organ Prolapse

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.